These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 675843)
1. Immunization against anaplasmosis and babesiosis. Part II. Evaluation of cryo-preserved vaccines using different doses and routes of inoculation. Todorovic R; Gonzalez E; Lopez G Tropenmed Parasitol; 1978 Jun; 29(2):210-4. PubMed ID: 675843 [TBL] [Abstract][Full Text] [Related]
2. Immunization against anaplasmosis and babesiosis: Part I. Evaluation of immunization using minimum infective doses under laboratory conditions. González EF; Todorovic RA; Thompson KC Tropenmed Parasitol; 1976 Dec; 27(4):427-37. PubMed ID: 1006801 [TBL] [Abstract][Full Text] [Related]
3. Infectivity of cryopreserved Babesia bovis, Babesia bigemina and Anaplasma centrale for cattle after thawing, dilution and incubation at 30 degrees C. Jorgensen WK; de Vos AJ; Dalgliesh RJ Vet Parasitol; 1989 Jun; 31(3-4):243-51. PubMed ID: 2763444 [TBL] [Abstract][Full Text] [Related]
4. Comparison of three methods of immunization against bovine anaplasmosis: evaluation of protection afforded against field challenge exposure. Vizcaino O; Corrier DE; Terry MK; Carson CA; Lee AJ; Kuttler KL; Ristic M; Treviño GS Am J Vet Res; 1980 Jul; 41(7):1066-8. PubMed ID: 7436100 [TBL] [Abstract][Full Text] [Related]
5. Preparation and laboratory testing of a frozen vaccine containing Babesia bovis, Babesia bigemina and Anaplasma centrale. Mellors LT; Dalgliesh RJ; Timms P; Rodwell BJ; Callow LL Res Vet Sci; 1982 Mar; 32(2):194-7. PubMed ID: 7079601 [TBL] [Abstract][Full Text] [Related]
6. Field challenge of cattle vaccinated with a combined Babesia bovis and Babesia bigemina frozen immunogen. Alvarez JA; Ramos JA; Rojas EE; Mosqueda JJ; Vega CA; Olvera AM; Figueroa JV; Cantó GJ Ann N Y Acad Sci; 2004 Oct; 1026():277-83. PubMed ID: 15604506 [TBL] [Abstract][Full Text] [Related]
7. Comparison of three methods of immunization against bovine anaplasmosis: an examination of postvaccinal effects. Corrier DE; Vizcaino O; Carson CA; Ristic M; Kuttler KL; Treviño GS; Lee AJ Am J Vet Res; 1980 Jul; 41(7):1062-5. PubMed ID: 7436099 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of attenuated Anaplasma marginale vaccine under laboratory and field conditions in Colombia. Vizcaino O; Carson CA; Lee AJ; Ristic M Am J Vet Res; 1978 Feb; 39(2):229-33. PubMed ID: 629456 [TBL] [Abstract][Full Text] [Related]
9. Effects of temperature and time on the infectivity of Cryogenically preserved samples of Anaplasma marginale- infected erythrocytes. Love JN; McEwen EG; Rubin RM Am J Vet Res; 1976 Jul; 37(7):857-8. PubMed ID: 937810 [TBL] [Abstract][Full Text] [Related]
10. Immunization of cattle with a Babesia bigemina antigen in Freund's complete adjuvant. Kuttler KL; Johnson LW Am J Vet Res; 1980 Apr; 41(4):536-8. PubMed ID: 7406273 [TBL] [Abstract][Full Text] [Related]
11. Post-thawing viability of vaccines for bovine babesiosis and anaplasmosis cryopreserved with glycerol. Mangold AJ; Aguirre DH; Guglielmone AA Vet Parasitol; 1990 Nov; 37(3-4):301-6. PubMed ID: 2267730 [TBL] [Abstract][Full Text] [Related]
12. Frozen and fresh Anaplasma centrale vaccines in the protection of cattle against Anaplasma marginale infection. Abdala AA; Pipano E; Aguirre DH; Gaido AB; Zurbriggen MA; Mangold AJ; Guglielmone AA Rev Elev Med Vet Pays Trop; 1990; 43(2):155-8. PubMed ID: 2092348 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for vaccine development against anaplasmosis and babesiosis. Palmer GH; McElwain TF Vet Parasitol; 1995 Mar; 57(1-3):233-53. PubMed ID: 7597787 [TBL] [Abstract][Full Text] [Related]
14. Estimation of the potential demand for a bovine babesiosis and anaplasmosis vaccine in Argentina. Späth EJ; Mangold AJ; Guglielmone AA Vet Parasitol; 1990 May; 36(1-2):131-40. PubMed ID: 2382381 [TBL] [Abstract][Full Text] [Related]
15. Immunization against anaplasmosis and babesiosis. Part III. Evaluation of immunization under field conditions in the Cauca River Valley. Todorovic RA; Gonzalez EF; Garcia O Tropenmed Parasitol; 1979 Mar; 30(1):43-52. PubMed ID: 442200 [TBL] [Abstract][Full Text] [Related]
16. Clinical features associated with seroconversion to Anaplasma marginale, Babesia bigemina and Theileria parva infections in African cattle under natural tick challenge. Magona JW; Walubengo J; Olaho-Mukani W; Jonsson NN; Welburn SC; Eisler MC Vet Parasitol; 2008 Aug; 155(3-4):273-80. PubMed ID: 18579313 [TBL] [Abstract][Full Text] [Related]
17. Immunization of bovines using a DNA vaccine (pcDNA3.1/MSP1b) prepared from the Jaboticabal strain of Anaplasma marginale. de Andrade GM; Machado RZ; Vidotto MC; Vidotto O Ann N Y Acad Sci; 2004 Oct; 1026():257-66. PubMed ID: 15604503 [TBL] [Abstract][Full Text] [Related]
18. Field observations on the duration of immunity in cattle after vaccination against Anaplasma and Babesia species. Tjornehoj K; Lawrence JA; Whiteland AP; Kafuwa PT Onderstepoort J Vet Res; 1996 Mar; 63(1):1-5. PubMed ID: 8848296 [TBL] [Abstract][Full Text] [Related]
19. Methods currently used for the control of anaplasmosis and babesiosis: their validity and proposals for future control strategies. Lawrence JA; de Vos AJ Parassitologia; 1990 Apr; 32(1):63-71. PubMed ID: 2284136 [TBL] [Abstract][Full Text] [Related]
20. Observations on the use of Anaplasma centrale for immunization of cattle against anaplasmosis in Zimbabwe. Turton JA; Katsande TC; Matingo MB; Jorgensen WK; Ushewokunze-Obatolu U; Dalgliesh RJ Onderstepoort J Vet Res; 1998 Jun; 65(2):81-6. PubMed ID: 9741051 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]